Julie CoakerTechnician
Email: julie.coaker@ncl.ac.uk Telephone: +44 (0) 191 241 8822 Fax: +44 (0) 191 241 8666 Address: Institute of Genetic Medicine
Burn J, Bishop DT, Chapman PD, Elliott F, Bertario L, Dunlop MG, Eccles D, Ellis A, Evans DG, Fodde R, Maher ER, Moslein G, Vasen HFA, Coaker J, Phillips RKS, Bulow S, Mathers JC, for the International CAPP Consortium. A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis .
Cancer Prevention Research 2011, 4 (5), 655-665.
Burn J, Chapman PD, Bishop DT, Dixon R, Turner F, Coaker J, Dunlop MG, Eccles D, Ellis A, Fidalgo P, Vasen HF, Fodde R, Moslein G, Bulow S, Phillips RKS, Bertario L, Evans G, Mathers J. Results of the CAPP1 Study: aspirin and resistant starch are beneficial in familial adenomatous polyposis .
In: American Journal of Human Genetics: Annual Meeting of the American Society of Human Genetics . 2003, Los Angeles, California, USA: Cell Press.
Armstrong F, Kirby J, Higgins CA, Coaker J, Mathers JC. High dose Hylon VII increases tumourigenesis and decreases lymphocyte proliferation in Min mice .
In: PROCEEDINGS OF THE NUTRITION SOCIETY . 2000.
Almeida M, Coaker J, Gunn A, Bradburn M, Curtis A, Burn J, Mathers JC, West SP. Hereditary nonpolyposis colorectal cancer (HNPCC) amongst patients with apparently sporadic colorectal cancer .
In: Journal of Medical Genetics . 1999, BMJ Group.
Williamson SLH, Kartheuser A, Coaker J, Kooshkghazi MD, Fodde R, Burn J, Mathers JC. Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months .
Carcinogenesis 1999, 20 (5), 805-810.
